Balyasny Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18M Sell
217,407
-60,598
-22% -$5.03M 0.03% 533
2025
Q1
$22.5M Buy
278,005
+81,631
+42% +$6.62M 0.04% 409
2024
Q4
$17.7M Buy
196,374
+91,538
+87% +$8.24M 0.03% 542
2024
Q3
$10.4M Sell
104,836
-139,104
-57% -$13.7M 0.02% 659
2024
Q2
$22.6M Buy
243,940
+85,112
+54% +$7.89M 0.04% 427
2024
Q1
$15.1M Sell
158,828
-14,010
-8% -$1.33M 0.03% 567
2023
Q4
$15.4M Sell
172,838
-10,011
-5% -$894K 0.03% 518
2023
Q3
$13.4M Buy
182,849
+176,260
+2,675% +$12.9M 0.03% 541
2023
Q2
$548K Sell
6,589
-44,949
-87% -$3.74M ﹤0.01% 1437
2023
Q1
$3.93M Buy
+51,538
New +$3.93M 0.01% 875
2022
Q4
Sell
-27,196
Closed -$2.16M 2794
2022
Q3
$2.16M Sell
27,196
-67,102
-71% -$5.32M 0.01% 1105
2022
Q2
$7M Buy
94,298
+56,482
+149% +$4.2M 0.02% 651
2022
Q1
$3.4M Sell
37,816
-20,192
-35% -$1.81M 0.01% 870
2021
Q4
$6.5M Buy
+58,008
New +$6.5M 0.02% 646
2021
Q3
Hold
0
2135
2020
Q3
Hold
0
1403
2020
Q2
Hold
0
1366
2019
Q4
Sell
-750,000
Closed -$57.2M 1390
2019
Q3
$57.2M Buy
+750,000
New +$57.2M 0.39% 46
2019
Q2
Hold
0
1588
2019
Q1
Hold
0
1556
2018
Q1
Sell
-219,000
Closed -$18.6M 2065
2017
Q4
$18.6M Buy
+219,000
New +$18.6M 0.06% 385
2017
Q3
Hold
0
1859
2017
Q2
Hold
0
1537
2017
Q1
Hold
0
1546
2016
Q3
Hold
0
1149
2016
Q2
Hold
0
1264
2016
Q1
Hold
0
1338
2015
Q3
Sell
-33,000
Closed -$2.78M 1202
2015
Q2
$2.78M Buy
+33,000
New +$2.78M 0.02% 504
2015
Q1
Hold
0
864